Inventor · disambiguated record
Prasanna Sivaprakasam
Also filed as: SIVAPRAKASAM PRASANNA
31 granted patents·8 pending applications·113 citations·filing 2014–2022
95Inventor score
Top patents by PatentIndex Score
39 records- 0196US10457681B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 29, 2019·15 cites·9 claims
- 0295US10869934B2Antiproliferative compounds and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 22, 2020·8 cites·1 claims
- 0395US10487084B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 26, 2019·16 cites·15 claims
- 0495US10472361B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 12, 2019·16 cites·6 claims
- 0594US10508115B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 17, 2019·13 cites·19 claims
- 0694US10494370B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 3, 2019·15 cites·6 claims
- 0792US11400094B22H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 2, 2022·4 cites·18 claims
- 0890US10752609B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 25, 2020·6 cites·10 claims
- 0989US10398783B2Antiproliferative compounds and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 3, 2019·7 cites·4 claims
- 1086US11554120B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 17, 2023·4 cites·13 claims
- 1180US9718804B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 1, 2017·5 cites·6 claims
- 1279US9409922B2Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replicationBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 9, 2016·3 cites·12 claims
- 1377US10723736B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·0 cites·1 claims
- 1477US10711003B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 1575US2023140047A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFORBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1674US10913741B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 9, 2021·0 cites·1 claims
- 1774US10689382B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 23, 2020·0 cites·1 claims
- 1873US10793569B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 6, 2020·0 cites·1 claims
- 1972US10941145B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 9, 2021·0 cites·1 claims
- 2072US10927114B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 23, 2021·0 cites·1 claims
- 2172US10919895B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 16, 2021·0 cites·1 claims
- 2272US10696676B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 30, 2020·0 cites·1 claims
- 2370US10351546B2Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Jul 16, 2019·1 cites·19 claims
- 2465US10981914B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 20, 2021·0 cites·2 claims
- 2555US12485123B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 2, 2025·0 cites·10 claims
- 2653US11053258B2Pyrimidine carboxamides as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 6, 2021·0 cites·9 claims
- 2753US2023122249A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2852US12492200B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Dec 9, 2025·0 cites·12 claims
- 2952US2023127326A1C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3052US2023144824A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3152US2023118688A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3250US10774086B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 15, 2020·0 cites·7 claims
- 3349US11485741B2Macrocyclic toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 3446US9809573B2Substituted pyridine derivatives useful as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 7, 2017·0 cites·3 claims
- 3545US12037344B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 16, 2024·0 cites·34 claims
- 3641US2020016136A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 3740US2020055839A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 3839US10221156B2Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
- 3938US2019010139A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →